Hims & Hers Health shares plunged Monday after the telehealth company said it would stop selling its compounded weight-loss ...

By Stine Jacobsen and Maggie Fick COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk sued Hims and Hers Health on Monday over patent ...

Feb 9 (Reuters) - Shares of Greggs fell as much as 6% on Monday after Jefferies warned that weight-loss drugs could curb ...

Novo's lawsuit comes less than one week after Hims & Hers announced plans to sell a compounded version of Novo's weight-loss ...

COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk's shares jumped more than 8% on Monday after telehealth firm Hims & Hers cancelled ...

By Stine Jacobsen and Maggie Fick COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk sued Hims and Hers Health on Monday over patent ...

Hims & Hers' gambit to sell a $49 compounded version of Novo Nordisk's Wegovy pill is rattling obesity shares, sparking ...

In today’s issue: Hims & Hers Health unveils cheaper Wegovy copycat, drawing legal threats from Novo Nordisk. … A key ...

Also in Celebrity: "'I Don’t Want To Orgasm Any More": My Jaw Is On The Floor After These 19 Actors Got Brutally Honest About ...

Melissa Joan Hart has lost nearly 20 pounds and is feeling “better than I have in a really long time.” The Sabrina the ...

When it comes to weight loss, research suggests exercise is not half as effective. It’s rather your diet that determines your ...

An experimental combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to late-stage trial data.